Carl Zeiss Meditec (ETR:AFX) received a €98.00 ($113.95) price target from stock analysts at Nord/LB in a research report issued on Thursday, Borsen Zeitung reports. The brokerage currently has a “neutral” rating on the stock. Nord/LB’s target price would suggest a potential upside of 2.14% from the stock’s previous close.
A number of other analysts also recently weighed in on AFX. HSBC set a €98.00 ($113.95) price target on shares of Carl Zeiss Meditec and gave the company a “neutral” rating in a report on Tuesday, September 17th. Berenberg Bank set a €93.00 ($108.14) price objective on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Wednesday. Hauck & Aufhaeuser set a €110.00 ($127.91) price objective on shares of Carl Zeiss Meditec and gave the stock a “buy” rating in a report on Thursday. Deutsche Bank set a €89.00 ($103.49) price objective on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Monday, August 12th. Finally, Independent Research set a €91.00 ($105.81) price objective on shares of Carl Zeiss Meditec and gave the stock a “sell” rating in a report on Monday, October 7th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and one has issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of €87.38 ($101.60).
Carl Zeiss Meditec stock traded up €3.40 ($3.95) during mid-day trading on Thursday, reaching €95.95 ($111.57). The company had a trading volume of 193,184 shares, compared to its average volume of 94,405. The company has a quick ratio of 3.09, a current ratio of 4.11 and a debt-to-equity ratio of 4.55. Carl Zeiss Meditec has a 52 week low of €60.25 ($70.06) and a 52 week high of €111.50 ($129.65). The company has a 50 day moving average of €103.64 and a 200-day moving average of €92.61. The firm has a market cap of $8.28 billion and a price-to-earnings ratio of 56.05.
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Featured Article: How does a reverse stock split work?
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.